TMEM94 and bacterial infectious disease: Future studies that allow us to know what the expression of the ermA, ermB, ermC genes is like against this tylosin, would allow us to innovate a biotechnological strategy that allows us to deal with bacterial infections using this antibiotic, minimizing the negative consequences for health.